Latest Form 4 insider transactions

Lisa E Storey, Chief Legal Officer of EverCommerce Inc., sold 17,012 shares of common stock on August 14, 2026 for $10.01 per share.

Peter W. Schneider, President of Primerica, Inc., sold 1,800 shares of common stock on August 17, 2026 for $312.65 per share.

Christian Todd Nichols, SVP, Chief Commercial Officer of Alkermes plc., sold 7,576 shares of common stock on August 17, 2026.

Amir F Heshmatpour, CEO, President, a Director and 10% owner of Neonc Technologies Holdings, Inc., purchased 15,000 shares of common stock on August 14, 2026.

Serena Jones and 1 other reported changes in beneficial ownership of Goosehead Insurance, Inc. common stock on August 13, 2026.

Siddharth Sitaram, Chief Accounting Officer of Doximity, Inc., sold 1,770 shares of common stock on August 13, 2026 for $24.94 per share.

Matthew Sonefeldt, Chief Financial Officer of Doximity, Inc., reported a transaction in 15,311 shares of common stock on August 15, 2026.

Steven L Zatz, President of Doximity, Inc., reported a transaction in 4,482 shares of common stock on August 15, 2026.

Jeffrey Tangney, Chief Executive Officer, a Director and 10% owner of Doximity, Inc., reported a transaction in 8,505 shares of common stock on August 15, 2026.

Michael Nofi, Chief Financial Officer of Edgewise Therapeutics, Inc., received 48,750 shares of common stock on August 12, 2026.

Joanne M. Donovan, CMO of Edgewise Therapeutics, Inc., received 65,000 shares of common stock on August 12, 2026.

Alan J Russell, Chief Scientific Officer and a Director of Edgewise Therapeutics, Inc., received 65,000 shares of common stock on August 12, 2026.

John R Moore, General Counsel of Edgewise Therapeutics, Inc., received 65,000 shares of common stock on August 12, 2026.

Behrad Derakhshan, Chief Business Officer of Edgewise Therapeutics, Inc., received 100,000 shares of common stock on August 12, 2026.

Bradley Mitchell Watkins, a Director of Neuraxis, INC, received 26,073 shares of common stock on August 13, 2026.

D Jonathan Merriman, a Director of PodcastOne, Inc., purchased 28,300 shares of common stock on August 14, 2026.

Adrian Miranda, CMO, SVP Science & Tech of Neuraxis, INC, received 133,341 shares of common stock on August 13, 2026.

Jane Elizabeth Keyser, a Director of Neuraxis, INC, received 26,073 shares of common stock on August 13, 2026.

James M Butler, SVP Chief Supply Chain Officer of Brinker International, Inc, reported multiple transactions in common stock on August 13, 2026.

David Sherry, Chief Financial Officer of ServiceTitan, Inc., sold 9,000 shares of common stock on August 14, 2026 for $90.83 per share.

Cindy L Davis, a Director of Brinker International, Inc, sold 1,775 shares of common stock on August 13, 2026 for $248.92 per share.

Anthony L Grande, EVP, Chief Development Officer of CoreCivic, Inc., sold 29,199 shares of common stock on August 17, 2026 for $33.61 per share.

Timothy Robert Henrichs, Chief Financial Officer of Neuraxis, INC, received 141,479 shares of common stock on August 13, 2026.

Kevin Hochman, Pres. & CEO and a Director of Brinker International, Inc, sold 40,000 shares of common stock on August 13, 2026 for $241.41 per share.

Kristin A Ferge, a Director of Neuraxis, INC, received 31,134 shares of common stock on August 13, 2026.

Thomas (Tc) Chan, Chief Accounting Officer of GoodRx Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

Douglas N. Comings, SVP & COO, Chili's of Brinker International, Inc, sold 5,000 shares of common stock on August 13, 2026 for $236.29 per share.

Xingjuan Chao, President and CEO and a Director of Ceribell, Inc., reported multiple transactions in common stock on August 13, 2026.

Justin Fengler, See Remarks of GoodRx Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

George S Felix, EVP, Chief Marketing Officer of Brinker International, Inc, sold 14,349 shares of common stock on August 13, 2026 for $237.47 per share.